Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The aim of this study was to assess whether two-year treatment with Pirfenidone influence necro-inflammation, fibrosis and steatosis in patients with chronic hepatitis C.
Epistemonikos ID: 8bacdc6fc3bf26bf9c54a3cf3d4e4d00e9b3e5e9
First added on: Mar 23, 2020